PET scan to measure gut scarring in Crohn's disease
Part of Digestive system clinical trials.
This study tests a new PET scan with a tracer called 68Ga-FAPI-46 to see how well it can find and measure scarring (fibrosis) in the small bowel caused by Crohn's disease. It may help doctors better understand and manage bowel damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have known Crohn's disease in the small bowel.
- You are 18 years or older.
- You had an MR or CT scan of your bowel within the last 3 months.
- You are willing to have a PET scan with an investigational tracer.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
This trial tests a new type of PET scan to see if it can accurately spot inflamed or damaged areas in the intestines of people with inflammatory bowel disease (IBD). If it works, it could help doctors track disease activity without relying only on invasive tests.
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
This study tests a new type of PET/CT scan that uses a special tracer to 'light up' areas of inflammation in the gut. The results will be compared with your endoscopy to see if this scan can help doctors track and manage inflammatory bowel disease more easily.
This study tests whether a new type of PET/CT scan can measure liver scarring (fibrosis) in people with fatty liver disease. It might help doctors check liver damage without needing repeated biopsies.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.